Literature DB >> 21854987

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.

Piyush B Gupta1, Christine M Fillmore, Guozhi Jiang, Sagi D Shapira, Kai Tao, Charlotte Kuperwasser, Eric S Lander.   

Abstract

Cancer cells within individual tumors often exist in distinct phenotypic states that differ in functional attributes. While cancer cell populations typically display distinctive equilibria in the proportion of cells in various states, the mechanisms by which this occurs are poorly understood. Here, we study the dynamics of phenotypic proportions in human breast cancer cell lines. We show that subpopulations of cells purified for a given phenotypic state return towards equilibrium proportions over time. These observations can be explained by a Markov model in which cells transition stochastically between states. A prediction of this model is that, given certain conditions, any subpopulation of cells will return to equilibrium phenotypic proportions over time. A second prediction is that breast cancer stem-like cells arise de novo from non-stem-like cells. These findings contribute to our understanding of cancer heterogeneity and reveal how stochasticity in single-cell behaviors promotes phenotypic equilibrium in populations of cancer cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21854987     DOI: 10.1016/j.cell.2011.07.026

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  630 in total

1.  Organ aging and susceptibility to cancer may be related to the geometry of the stem cell niche.

Authors:  Krastan B Blagoev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.

Authors:  Yan Zhou; Jiyuan Yang; Jindřich Kopeček
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

Review 3.  Emerging role of microRNAs in drug-resistant breast cancer.

Authors:  Sarmila Majumder; Samson T Jacob
Journal:  Gene Expr       Date:  2011

4.  Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells.

Authors:  Kamola Saydaminova; Robert Strauss; Min Xie; Jiri Bartek; Maximilian Richter; Ruan van Rensburg; Charles Drescher; Anja Ehrhardt; Sheng Ding; André Lieber
Journal:  Cancer Biol Ther       Date:  2016-08-30       Impact factor: 4.742

5.  Impact of deleterious passenger mutations on cancer progression.

Authors:  Christopher D McFarland; Kirill S Korolev; Gregory V Kryukov; Shamil R Sunyaev; Leonid A Mirny
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

Review 6.  Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.

Authors:  Zhishan Wang; Chengfeng Yang
Journal:  Semin Cancer Biol       Date:  2019-01-11       Impact factor: 15.707

Review 7.  Life history trade-offs in cancer evolution.

Authors:  C Athena Aktipis; Amy M Boddy; Robert A Gatenby; Joel S Brown; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2013-11-11       Impact factor: 60.716

8.  Is reliance on mitochondrial respiration a "chink in the armor" of therapy-resistant cancer?

Authors:  Dieter A Wolf
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

9.  HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects.

Authors:  Yan Zhou; Jiyuan Yang; Johng S Rhim; Jindřich Kopeček
Journal:  J Control Release       Date:  2013-09-14       Impact factor: 9.776

Review 10.  Genomic profiling in triple-negative breast cancer.

Authors:  Cornelia Liedtke; Christof Bernemann; Ludwig Kiesel; Achim Rody
Journal:  Breast Care (Basel)       Date:  2013-12       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.